FUS and pilomyxoid astrocytoma: Our current findings demonstrate that mutations in SOD1, ANG, FUS/TLS, TARDBP and CHMP2B are also associated with apparently sporadic PMA, thus expanding the wide range of clinical phenotypes reported to date.